Register entry
- Registered sites
- 0
- Active NDC listings
- 6
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
66 active NDC listings: 6 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 6.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 6 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| aesica queenborough limited | 6 |
Catalogue
Marketed products
6| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Ivacaftor | tablet, film coated | 43798-005DRUG FOR FURTHER PROCESSING |
| - | Lumacaftor and Ivacaftor | tablet, film coated | 43798-004DRUG FOR FURTHER PROCESSING |
| - | Lumacaftor/Ivacaftor Paediatric | tablet, film coated | 43798-014DRUG FOR FURTHER PROCESSING |
| - | Metformin Hydrochloride and Sitagliptin Phosphate | tablet, film coated | 43798-001DRUG FOR FURTHER PROCESSING |
| - | Metformin Hydrochloride and Sitagliptin Phosphate | tablet, film coated | 43798-002DRUG FOR FURTHER PROCESSING |
| - | Metformin Hydrochloride and Sitagliptin Phosphate | tablet, film coated | 43798-003DRUG FOR FURTHER PROCESSING |
Enquiry
Common questions
- Is Aesica Queenborough Limited FDA approved?
- Aesica Queenborough Limited holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Aesica Queenborough Limited make?
- 6 products are listed under Aesica Queenborough Limited in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.